Tonix Pharmaceuticals Holding Corp. — Form 8-K
Filed August 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Form 8-K filed 2026-08-18 reports Item 5.02 (departure of directors/officers and compensatory arrangements) and Item 8.01 (other events). No specific names, dollar amounts, dates, or details of the departure or arrangements are provided in the header metadata. Full filing text required to identify counterparties, compensation figures, or business impact.
Why this rating
Header alone provides no specifics on departure severity, role, or compensation. Cannot assess materiality without detailed filing content. Routine officer transitions are common disclosures.
Extracted items
- 5.02 exec change
- 8.01 other event
See more from August 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.